Sensitive ASX Announcement

Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study

Published: 03/10/24, 09:33am (AEST)3 pages
Lumos Diagnostics Holdings
LDX:ASXHealthcare

Recent LDX Announcements

Price Sensitive only